Position in AZN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,155,815,432
+$22,374,937 QoQ
Shares Held
6,095,430
+6.1% QoQ
Ownership
0.393%
of shares outstanding
% of Portfolio
0.29%
of 13F equity value
Holder Rank
#35
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 70%
None 30%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026AMERIPRISE FINANCIAL INC holds $17,081,497,167 across 17 Drug Manufacturers - General names. AZN ranks #6 (6.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
2,996,669 | $3,594,294,994 | |
| 2 | JNJ |
Johnson & Johnson
|
13,401,691 | $3,403,627,461 | |
| 3 | ABBV |
AbbVie Inc.
|
11,519,507 | $2,898,768,740 | |
| 4 | MRK |
Merck & Co., Inc.
|
17,387,435 | $2,234,285,396 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
26,670,064 | $1,536,729,084 | |
| 6 | AZN |
Astrazeneca PLC
This page
|
6,095,430 | $1,155,815,432 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
7,618,082 | $962,468,477 | |
| 8 | AMGN |
Amgen Inc
|
1,897,321 | $687,057,877 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,155,815,432 | 6,095,430 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,133,440,495 | 5,747,087 | Shares | Defined | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||